Article Figures & Tables
Figures
Figure 1: Odds of postdischarge use of β-blockers, angiotensin-modifying agents (angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers) and statins among elderly patients with acute myocardial infarction (AMI), in 2005/06. Note: CI = confidence interval.
Tables
Table 1.
Table 2.
Table 3.
In this issue
Article tools
Respond to this article
Jump to section
Related Articles
Cited By...
- Resource Effective Strategies to Prevent and Treat Cardiovascular Disease
- Relationship Between Care Gaps and Projected Life Expectancy After Acute Myocardial Infarction
- Closing the gap in postfracture care at the population level: a randomized controlled trial
- Physician and Patient Influences on Provider Performance: {beta}-Blockers in Postmyocardial Infarction Management in the MI-Plus Study
- 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
- Temperature changes and the risk of cardiac events
- Myocardial infarction and quality of care
More in this TOC Section
Similar Articles
